Ionis Pharmaceuticals, Inc.
1026 articles about Ionis Pharmaceuticals, Inc.
-
Isis Pharmaceuticals, Inc. New Data Presented at ACC Show ISIS 301012 Monotherapy Reduces apoB to Undetectable Levels and Reduces LDL-C 70%
3/26/2007
-
Isis Pharmaceuticals, Inc. (Jobs) Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC
3/26/2007
-
Isis Pharmaceuticals, Inc. Announces Its Participation at the Upcoming ACC 56th Annual Scientific Session in New Orleans and Its Live Analyst/Investor Webcast Presentation
3/22/2007
-
Isis Pharmaceuticals, Inc. Reports Financial Results and Highlights for Fiscal Year 2006
3/8/2007
-
Lipomics Technologies, Inc. To Support Isis Pharmaceuticals, Inc. In Preclinical And Clinical Studies Of Metabolic Drug Candidates
2/14/2007
-
Isis Pharmaceuticals, Inc. Completes Offering Of $125 Million Convertible Subordinated Notes To Refinance Existing $125 Million Convertible Subordinated Notes
1/24/2007
-
Isis Pharmaceuticals, Inc. Announces Appointment Of Jeffrey M. Jonas, M.D. As Executive Vice President
1/22/2007
-
Isis Pharmaceuticals, Inc. Enters Into An Agreement To Sell $125.0 Million Convertible Subordinated Notes Due 2027 To Refinance Existing $125.0 Million Convertible Subordinated Notes Due 2009
1/18/2007
-
Isis Pharmaceuticals, Inc. Announces Offering Of Convertible Subordinated Notes
1/17/2007
-
Isis Pharmaceuticals, Inc. Development Partner iCo Therapeutics Inc. Files IND For Antisense Drug To Treat Eye Disease
12/21/2006
-
European Patent Office Upholds Key Isis Pharmaceuticals, Inc. Patent Protecting Antisense Structures
12/20/2006
-
Isis Pharmaceuticals, Inc. And Alnylam Pharmaceuticals Announce Issued U.S. Patent Broadly Covering Chemical Modifications Of Oligonucleotide Therapeutics
11/27/2006
-
Isis Pharmaceuticals, Inc. Announces Its Analyst/Investor Webcast Presentation
11/9/2006
-
Isis Pharmaceuticals, Inc. Reports Financial Results And Highlights For Third Quarter Of 2006
11/2/2006
-
Isis Pharmaceuticals, Inc. Announces Third Quarter 2006 Financial Results Webcast
10/26/2006
-
Isis Pharmaceuticals, Inc. Receives First Commercial Order For Ibis T5000 Biosensor Systems
10/3/2006
-
Isis Pharmaceuticals, Inc.'s Ibis T5000 Universal Biosensor System Highlighted At ICAAC
9/29/2006
-
Webcast Alert: Isis Pharmaceuticals, Inc. Announces Ibis Division Analyst Day Webcast
9/28/2006
-
Isis Pharmaceuticals, Inc. To Present At The UBS Warburg Global Life Sciences Conference
9/25/2006
-
Bruker Daltonics Inc. And Isis Pharmaceuticals, Inc. Announce the European Introduction Of The Ibis T5000 Biosensor System
9/25/2006